SVB Asset Management

SAM Advantages

Contact SVB Asset Management

SAM Advantages

SVB Asset Management. At SVB Asset Management ("SAM"), we strive to help our clients protect their capital and achieve their investment goals through outsourced treasury and customized cash portfolio management. The SAM team has the expertise and resources to manage your investment portfolio within the guidelines you establish, so you can remain focused on building your business, not managing your investments. SAM serves its clients by expertly addressing regulatory challenges, portfolio management excellence and an unparalleled focus on our clients and their asset management needs.

Our History Of Investment Management. SVB Financial Group and its investment affiliates, SVB Securities and SVB Asset Management have a long and successful history of providing investment services to our clients. We've managed the investments of some of the technology and life science industries' most successful, entrepreneurial companies. Our experience extends from 1993, when SVB began offering securities through its corporate treasury unit, through 2007 when invested client assets for SVB Financial Group and its affiliates exceeded $22 billion.

Portfolio Management Excellence. SAM has over 60 years combined management experience upon which to draw to help our clients preserve capital and maintain liquidity while working to achieve maximum returns. Our dedicated portfolio managers execute clients' uniquely tailored investment strategies while monitoring and proactively planning for clients' changing liquidity needs. An external benchmark goal is used to evaluate portfolio performance, providing a high level of accountability and investment transparency.

Independence. SAM's independence and objectivity are its greatest assets. SAM does not underwrite any securities, mitigating a key conflict of interest. Our dedicated staff maintains relationships with more than 30 dealers to allow for best execution opportunities on all trades. Our fee structure is all-inclusive, with no commissions hidden in the prices of securities, ensuring our alignment with client objectives.

Central to our independence advantage is our ability to offer our clients premium independent asset pricing, portfolio accounting and performance measurement that undergoes a Type II SAS 70 audit three times annually. SAM also utilizes a third-party custodian to provide a clear check-and-balance system between the investment function and the asset safekeeping function.

Focus On Our Clients. SAM's focus on our clients is unmatched by any competitor. SAM works exclusively with clients in the technology and life science industries, maximizing our expertise and experience. Additionally, SAM is strictly focused on short-term cash management. In order to be responsive to our clients' dynamic investment needs, every member of the SAM team is available and accessible to our clients.

Challenges
Sarbanes-Oxley New Regulatory and Accounting Challenges Increased Strategic Role of Cash and Treasury	Improving Treasury Productivity Optimization of Cash Flow Type II SAS 70 Verifications Across all Controls

SAM Solutions
SAM, Custodian and Reporting-Specific Type II SAS 70s Uniform GAAP and FASB Standards Close-ready GL Debits and Credits Real-time Accounting Information, 1st Day Close	Customized Daily Compliance Verification Compliance Violation Notification and Audit Trail Benchmarked Risk Analysis Benchmarked GIPS®-Compliant Reporting

Results
Cash Forecasting Accuracy Streamlined Audit and Compliance Data Transparency and Accuracy	Performance Visibility Risk Reduction Increased Efficiency Greater Confidence

Select Client List

3Par, Inc.
Active Power, Inc.
Airspan Networks, Inc.
Atherogenics, Inc.
ATS Medical, Inc.
Bottomline Technologies, Inc.
Collagenex Pharmaceuticals
Cougar Biotechnology, Inc.
Cypress Semiconductor, Inc.
DivX, Inc.
Equinix, Inc.
Evergreen Solar, Inc.
Enanta Pharmaceuticals, Inc.
Finisar Corporation
Gracenote
Harmonic, Inc.
Harris Stratex Networks
I Flow Corporation
Isilon Systems, Inc.
Isis Pharmaceuticals, Inc.
Kayak Software
LifeCell Corporation
Moldflow Corporation
Motive, Inc.
Napster, Inc.
NovaTel Ltd.
Nuvelo, Inc.
OXiGENE, Inc.
Solfocus, Inc.
Sirion Therapeutics, Inc.
Sumtotal Systems, Inc.
Sybase, Inc.
Xoom Corp.
Zhone Technologies, Inc.
Zars Pharma, Inc.

SVB Asset Management Client Base
(as of 1.31.2008)

Clients by Industry

Clients by Ownership

Clients by Region

The companies listed in this document represent a sample of SVB Asset Management ("SAM") clients, and were selected to illustrate the types of companies for whom SAM provides investment management services. No performance criteria were used in the selection. The companies have authorized SAM to use their company name and logo, however, this does not imply an endorsement or testimonial as to SAM or the investment advisory services we provide.

This material, including without limitation the statistical information herein, is provided for informational purposes only. The material is based in part upon information from third-party sources that we believe to be reliable, but which has not been independently verified by us and, as such, we do not represent that the information is accurate or complete. The information should not be viewed as tax, investment, legal or other advice nor is it to be relied on in making an investment or other decisions. You should obtain relevant and specific professional advice before making any investment decision. Nothing relating to the material should be construed as a solicitation or offer, or recommendation, to acquire or dispose of any investment or to engage in any other transaction.

The value of the securities or financial instruments mentioned herein (including the income derived therefrom) may be adversely affected by changes in market prices and exchange rates and the imposition of taxes and other factors. Prices, opinions and estimates reflect our judgment on the date of original publication and are subject to change at any time without notice. Information concerning past performance is not necessarily a guide to future performance.

Financial instruments discussed herein may not be suitable or appropriate for all investors or in all geographical areas. Your particular financial service needs and financial situation were not taken into account in the preparation of this document. You must make your own independent decisions regarding any financial instruments mentioned herein. You should consider whether the purchase or sale of any financial products, including foreign currencies, is appropriate for you in the light of your particular financial needs, objectives and financial circumstances.